Transgene operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Transgene with three other
pharmaceutical manufacturers in Europe:
sales of 5.62 million Euro [US$6.11 million]
Biomed Lublin Wytwornia Surowic I Szczepionek SA
(42.59 million Polish New Zlotys [US$10.71 million]
Co Don AG
based in Germany
(5.09 million Euro [US$5.53 million]
of which 100%
was Product sales).
During the year ended December of 2015, sales at
Transgene were 9.57 million Euro (US$10.41 million).
decrease of 18.6%
versus 2014, when the company's sales were 11.75 million Euro.